# Visualizing Genetics: An Investigation of Dermoscopy as a Tool for Genetic Variant Prediction in Capillary Malformations

**Authors:** Aretha On, Marie-Chantal Caussade, Allison Britt, Sarah E. Sheppard, Denise Adams, Griffin Stockton Hogrogian, James R. Treat

PMC · DOI: 10.1111/pde.70036 · 2026-01-24

## TL;DR

This study explores how dermoscopy can help predict genetic variants in capillary malformations, potentially improving diagnosis and treatment.

## Contribution

The study identifies distinct dermoscopic features linked to specific genetic variants in capillary malformations.

## Key findings

- EPHB4-CMs show branching vessel patterns in dermoscopic images.
- RASA1-CMs typically appear as red/pink/brown without visible vessels.
- PIK3CA-CMs with purple lacunae suggest a lymphatic component.

## Abstract

Capillary malformations (CMs) are congenital malformations of capillaries typically visible as blanchable, pink to brown patches on the skin and/or mucosa. The genetic cause of CMs guides diagnosis, treatment, and recurrence counseling. However, identification may be limited by the availability of samples, the type of tests, and insurance coverage. We hypothesize that there are distinct dermoscopic features associated with specific genotypes of congenital CMs.

A single-center, retrospective cohort study of 22 patients with CMs affecting the skin, a polarized dermoscopic photo of the lesion, and a single nucleotide variant in the EPHB4, GNA11/GNAQ, PIK3CA/PIK3R1, or RASA1 genes was performed. Three reviewers analyzed dermoscopic photos for the presence of apparent vessels, branching, lacunae, geometric shape formation, zones of dropout, follicle-sparing, vessel and background color, and length and width of vessels when discernable. Features were categorized by genotype.

EPHB4-CMs have visible lengthwise and widthwise cross sections of vessels that exhibit branching. RASA1-CMs generally present with merely a red/pink/brown hue without visible vessels. GNA11 or GNAQ-CMs generally present with pink coloration and generally only with visible widthwise cross sections of vessels without branching. Geometric PIK3CA-CMs exhibit distinct purple lacunae that indicate a lymphatic component, but the reticulated PIK3CA-CMs otherwise demonstrate a varied presentation.

Our research identified distinct genotype–phenotype correlations for CMs by dermoscopy. Dermoscopy can narrow the differential diagnosis, guide genetic testing, and aid in the interpretation of variants of uncertain significance (VUS). This study demonstrates that dermoscopy holds promise in aiding genetic diagnosis and ultimately medical management.

## Linked entities

- **Genes:** EPHB4 (EPH receptor B4) [NCBI Gene 2050], GNA11 (G protein subunit alpha 11) [NCBI Gene 2767], GNAQ (G protein subunit alpha q) [NCBI Gene 2776], PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) [NCBI Gene 5290], PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 5295], RASA1 (RAS p21 protein activator 1) [NCBI Gene 5921]

## Full-text entities

- **Genes:** PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 5295] {aka AGM7, GRB1, IMD36, p85, p85-ALPHA, p85alpha}, GNAQ (G protein subunit alpha q) [NCBI Gene 2776] {aka CMAL, G-ALPHA-q, GAQ, SWS}, GNA11 (G protein subunit alpha 11) [NCBI Gene 2767] {aka FBH, FBH2, FHH2, GNA-11, HG1K, HHC2}, EPHB4 (EPH receptor B4) [NCBI Gene 2050] {aka CMAVM2, HFASD, HTK, LMPHM7, MYK1, TYRO11}, PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) [NCBI Gene 5290] {aka CCM4, CLAPO, CLOVE, CWS5, HMH, MCAP}, RASA1 (RAS p21 protein activator 1) [NCBI Gene 5921] {aka CM-AVM, CMAVM, CMAVM1, GAP, PKWS, RASA}
- **Diseases:** CMs (OMIM:163000)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12828651/full.md

---
Source: https://tomesphere.com/paper/PMC12828651